713530-56-4 Usage
Description
6-BROMO-2-METHYL-4-NITRO-1H-BENZO[D]IMIDAZOLE is a nitroimidazole derivative with the molecular formula C8H6BrN3O2. It features a bromine atom and a methyl group on the benzene ring, along with a nitro group attached to the imidazole ring. This chemical compound is recognized for its versatile reactivity and potential biological activity, making it a valuable intermediate in the synthesis of pharmaceuticals and agrochemicals.
Used in Pharmaceutical Industry:
6-BROMO-2-METHYL-4-NITRO-1H-BENZO[D]IMIDAZOLE is used as a building block for the synthesis of various pharmaceuticals due to its unique structure and properties. It plays a crucial role in the development of new drugs, contributing to medicinal chemistry and drug discovery.
Used in Agrochemical Industry:
In the agrochemical field, 6-BROMO-2-METHYL-4-NITRO-1H-BENZO[D]IMIDAZOLE is utilized as a key intermediate in the production of agrochemicals. Its reactivity and potential biological activity make it an essential component in the synthesis of compounds used for agricultural applications.
Check Digit Verification of cas no
The CAS Registry Mumber 713530-56-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,3,5,3 and 0 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 713530-56:
(8*7)+(7*1)+(6*3)+(5*5)+(4*3)+(3*0)+(2*5)+(1*6)=134
134 % 10 = 4
So 713530-56-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H6BrN3O2/c1-4-10-6-2-5(9)3-7(12(13)14)8(6)11-4/h2-3H,1H3,(H,10,11)
713530-56-4Relevant articles and documents
COMPOUND FUNCTIONING AS BROMODOMAIN PROTEIN INHIBITOR, AND COMPOSITION
-
Paragraph 0153; 0154; 0194; 0196, (2020/11/22)
The invention relates to a bromodomain inhibitor. The invention also provides compositions and formulations comprising such compounds, and methods of using and preparing such compounds.
NOVEL BICYCLIC BROMODOMAIN INHIBITORS
-
Paragraph 0218, (2015/01/16)
The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.
CYCLIC BENZIMIDAZOLES
-
Page 39, (2010/02/08)
The invention relates to cyclic benzimidazoles of formula (1), (1) in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion inhibiting and excellent gastric and intestinal protective action properties.
